Trimetazidine Hydrochloride Extended-Release Tablets are used as an add-on medication for the symptomatic treatment of adult patients with stable angina who are poorly controlled or intolerant of first-line antianginal therapy. Adverse reactions such as headache, dizziness, abdominal pain and diarrhea, dyspepsia, nausea and vomiting, rash, itching, urticaria, weakness, palpitations, and flushing may occur with the administration of Trimetazidine Hydrochloride Extended-Release Tablets. It is contraindicated in people who are allergic to any of the components of this product, in patients with Parkinson’s disease, tremor, restless leg syndrome, and other related movement disorders, and in patients with severe renal impairment. Use with caution in patients with moderate renal impairment, use with caution in elderly patients over 75 years of age, use with caution in lactating women, use with caution in athletes. If you need to use Trimetazidine Hydrochloride Extended-Release Tablets, please consult a professional doctor, follow the doctor’s instructions, and use medication reasonably.